Michael Burry’s Scion Asset Management disclosed a major reshuffling of its portfolio in its Q3 2025 13F filing, unveiling new bearish bets against artificial intelligence leaders Nvidia ($NVDA) and Palantir ($PLTR), while adding large call positions in traditional energy and healthcare names. The filing highlights a renewed tilt toward defensive sectors, with notable moves in Halliburton and Pfizer.
You can view his full holdings here.
You can copytrade a strategy based on his portfolio here.
- New Put Options: Opened substantial bearish positions against Nvidia ($NVDA) and Palantir ($PLTR). Nvidia and Palantir are up 54% and 174% year-to-date respectively.
- New Call Options: Added bullish exposure to Halliburton ($HAL) and Pfizer ($PFE) through sizable call option positions, signaling increased interest in energy and pharmaceutical sectors.
- Exited Option Positions: Burry closed out of all of his option positions from the previous quarter. This includes bullish call option holdings in Lululemon ($LULU), Meta ($META), ASML ($ASML), and Alibaba ($BABA), among others.
- Equity Holdings: Burry doubled stock his holdings in Lululemon ($LULU) to 100,000 shares but closed out of the rest of the equity positions he reported in Q2. He did open new positions in SLM Corporation ($SLM), and Molina Healthcare Inc. ($MOH).
Relevant Companies
- Nvidia ($NVDA) — Target of new large put option positions.
- Palantir ($PLTR) — Subject to new bearish bets from Scion Asset Management.
- Halliburton ($HAL) — Added as a major new bullish call option position.
Editor’s Note: This is a developing story. This article may be updated as more details become available.
